Curis Announces Closing of $30 Million Secured Debt Financing

Curis Announces Closing of $30 Million Secured Debt Financing

[at noodls] – LEXINGTON, Mass., Dec. 12, 2012 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view

Share this post